NVONovo Nordisk A/S
Healthcare · Drug Manufacturers - GeneralNYSEStockMkt cap $200.6B
Disclosed trades
43
1 in 30d · 1 in 90d
Politicians
13
Last trade Aug 26, 2026
Buys
26
$795.5K at range midpoints
Sells
13
$687K at range midpoints
Closing price · 365 days
Sep 24, 2025 – Sep 23, 2026
Monthly buys vs sells · 24 months
Counts of disclosed transactions
- Buys
- Sells (incl. partial)
Politicians who traded it
| Politician | Seat | Trades | Buys | Sells | Bought (mid) | Sold (mid) | Last trade |
|---|---|---|---|---|---|---|---|
| RMichael T. McCaul | House · TX-10 | 11 | 6 | 1 | $537.5K | $32.5K | Jul 5, 2025 |
| RLisa C. McClain | House · MI-09 | 7 | 3 | 4 | $24K | $32K | Oct 31, 2025 |
| RScott Franklin | House · FL-18 | 7 | 7 | 0 | $105K | $0 | Aug 26, 2026 |
| RByron Donalds | House · FL-19 | 4 | 2 | 2 | $16K | $16K | Mar 20, 2025 |
| RMarjorie Taylor Greene | House · GA-14 | 3 | 3 | 0 | $48.5K | $0 | Oct 15, 2025 |
| DDaniel S. Goldman | House · NY-10 | 2 | 0 | 2 | $0 | $550K | Jul 12, 2023 |
| RJohn James | House · MI-10 | 2 | 1 | 1 | $8K | $8K | Sep 4, 2024 |
| DKatherine M. Clark | House · MA-05 | 2 | 2 | 0 | $16K | $0 | Nov 5, 2020 |
| RAlan Armstrong | Senate · OK | 1 | 1 | 0 | $32.5K | $0 | Mar 30, 2026 |
| RLaurel M. Lee | House · FL-15 | 1 | 0 | 1 | $0 | $8K | May 8, 2025 |
| DMikie Sherrill | House · NJ-11 | 1 | 0 | 1 | $0 | $8K | Feb 20, 2020 |
| RTommy Tuberville | Senate · AL | 1 | 0 | 1 | $0 | $32.5K | Jan 19, 2024 |
| DVal T. Hoyle | House · OR-04 | 1 | 1 | 0 | $8K | $0 | Oct 29, 2024 |
Recent trades
| Politician | Ticker | Asset | Type | Owner | Amount | Traded | Filed | Source |
|---|---|---|---|---|---|---|---|---|
| RScott Franklin | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $1,001 - $15,000 | Aug 26, 2026 | Sep 17, 202622d | Filing |
| RAlan Armstrong | NVO | Novo Nordisk A/S Common Stock | Buy | Self | $15,001 - $50,000 | Mar 30, 2026 | Jul 21, 2026113d | Filing |
| RLisa C. McClain | NVO | Novo Nordisk A/S Common Stock (NVO) | Sell | Spouse | $1,001 - $15,000 | Oct 31, 2025 | Nov 21, 202521d | Filing |
| RLisa C. McClain | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Spouse | $1,001 - $15,000 | Oct 30, 2025 | Nov 21, 202522d | Filing |
| RLisa C. McClain | NVO | Novo Nordisk A/S Common Stock (NVO) | Sell | Spouse | $1,001 - $15,000 | Oct 30, 2025 | Nov 21, 202522d | Filing |
| RLisa C. McClain | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Spouse | $1,001 - $15,000 | Sep 11, 2025 | Oct 22, 202541d | Filing |
| RMarjorie Taylor Greene | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $1,001 - $15,000 | Oct 15, 2025 | Oct 20, 20255d | Filing |
| RLisa C. McClain | NVO | Novo Nordisk A/S Common Stock (NVO) | Partial | Spouse | $1,001 - $15,000 | Aug 4, 2025 | Sep 12, 202539d | Filing |
| DVal T. Hoyle | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Spouse | $1,001 - $15,000 | Oct 29, 2024 | Sep 12, 2025318d | Filing |
| RMarjorie Taylor Greene | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $1,001 - $15,000 | Aug 28, 2025 | Aug 29, 20251d | Filing |
| RMarjorie Taylor Greene | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $15,001 - $50,000 | Aug 19, 2025 | Aug 20, 20251d | Filing |
| RScott Franklin | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Spouse | $1,001 - $15,000 | Aug 4, 2025 | Aug 14, 202510d | Filing |
| RScott Franklin | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $1,001 - $15,000 | Aug 4, 2025 | Aug 14, 202510d | Filing |
| RScott Franklin | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $1,001 - $15,000 | Aug 4, 2025 | Aug 14, 202510d | Filing |
| RScott Franklin | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $15,001 - $50,000 | Aug 4, 2025 | Aug 14, 202510d | Filing |
| RLisa C. McClain | NVO | Novo Nordisk A/S Common Stock (NVO) | Partial | Spouse | $1,001 - $15,000 | Jul 10, 2025 | Aug 13, 202534d | Filing |
| RLisa C. McClain | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Spouse | $1,001 - $15,000 | Jun 9, 2025 | Aug 13, 202565d | Filing |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | UnknownReview | Unknown | $50,001 - $100,000 | Jul 5, 2025 | Jul 7, 20252d | FilingOCR |
| RLaurel M. Lee | NVO | Novo Nordisk A/S Common Stock (NVO) | Partial | Spouse | $1,001 - $15,000 | May 8, 2025 | Jun 22, 202545d | Filing |
| RByron Donalds | NVO | Novo Nordisk A/S Common Stock (NVO) | Sell | Spouse | $1,001 - $15,000 | Mar 20, 2025 | Apr 14, 202525d | Filing |
| RByron Donalds | NVO | Novo Nordisk A/S Common Stock (NVO) | Sell | Self | $1,001 - $15,000 | Mar 20, 2025 | Apr 14, 202525d | Filing |
| RScott Franklin | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $15,001 - $50,000 | Mar 27, 2025 | Apr 11, 202515d | Filing |
| RScott Franklin | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $1,001 - $15,000 | Mar 27, 2025 | Apr 11, 202515d | Filing |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | BuyReview | Unknown | $15,001 - $50,000 | — | Jan 15, 2025 | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | BuyReview | Spouse | $15,001 - $50,000 | — | Jan 15, 2025 | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | SellReview | Dependent | $15,001 - $50,000 | — | Dec 16, 2024 | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | ExchangeReview | Dependent | $15,001 - $50,000 | Nov 5, 2024 | Nov 12, 20247d | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | ExchangeReview | Spouse | $15,001 - $50,000 | Nov 5, 2024 | Nov 12, 20247d | FilingOCR |
| RByron Donalds | NVO | Novo-Nordisk As Adr (NVO) | BuyReview | Spouse | $1,001 - $15,000 | Oct 7, 2022 | Nov 8, 2024763d | FilingOCR |
| RByron Donalds | NVO | Novo-Nordisk As Adr (NVO) | BuyReview | Self | $1,001 - $15,000 | Oct 7, 2022 | Nov 8, 2024763d | FilingOCR |
| RJohn James | NVO | Novo Nordisk A/S Common Stock (NVO) | Sell | Self | $1,001 - $15,000 | Sep 4, 2024 | Sep 6, 20242d | Filing |
| RJohn James | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $1,001 - $15,000 | Nov 10, 2023 | Sep 2, 2024297d | Filing |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | Exchange | Spouse | $15,001 - $50,000 | Jun 5, 2024 | Jun 13, 20248d | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | BuyReview | Dependent | $15,001 - $50,000 | — | Jun 13, 2024 | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | BuyReview | Dependent | $15,001 - $50,000 | — | Jun 13, 2024 | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK AS ADR | BuyReview | Spouse | $15,001 - $50,000 | — | Jun 13, 2024 | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISKAS ADR | BuyReview | Unknown | $250,001 - $500,000 | — | May 11, 2024 | FilingOCR |
| RTommy Tuberville | NVO | Novo Nordisk A/S Common Stock | Sell | Joint | $15,001 - $50,000 | Jan 19, 2024 | Feb 14, 202426d | Filing |
| DDaniel S. Goldman | NVO | Novo Nordisk A/S (NVO) | Sell | Self | $100,001 - $250,000 | Jul 12, 2023 | Aug 13, 202332d | Filing |
| DDaniel S. Goldman | NVO | Novo Nordisk A/S (NVO) | Sell | Self | $250,001 - $500,000 | Jul 10, 2023 | Aug 13, 202334d | Filing |
| DKatherine M. Clark | NVO | Novo Nordisk A/S (NVO) | Buy | Spouse | $1,001 - $15,000 | Nov 5, 2020 | Dec 28, 202053d | Filing |
| DKatherine M. Clark | NVO | Novo Nordisk A/S (NVO) | Buy | Spouse | $1,001 - $15,000 | Nov 5, 2020 | Dec 28, 202053d | Filing |
| DMikie Sherrill | NVO | Novo Nordisk a/S (NVO) | Sell | Self | $1,001 - $15,000 | Feb 20, 2020 | Apr 5, 202045d | Filing |
Unusual activity Estimated
- 58Well timedMar 30, 2026
Sen. Alan Armstrong's NVO buy is up 33% after 30 days
Details
- Politician
- Alan Armstrong
- Ticker
- NVO
- Asset
- Novo Nordisk A/S Common Stock
- Tx type
- buy
- Tx date
- Mar 30, 2026
- Filing date
- Jul 21, 2026
- Amount low
- $15,001
- Amount high
- $50,000
- Amount mid
- $32,501
- Disclosed range
- $15,001 - $50,000
- Reporting lag days
- 113
- Is whale
- No
- Entry date
- Mar 30, 2026
- Entry close
- 35.29
- Exit date
- May 12, 2026
- Exit close
- 47
- Forward return
- +33.2%
- Sign adjusted return
- +33.2%
- N trading days
- 30
- 43Committee overlapMar 30, 2026
Sen. Alan Armstrong bought $15,001–$50,000 of NVO while sitting on Senate Health
Details
- Committee
- Senate Committee on Health, Education, Labor, and Pensions
- Leadership seat
- No
- Sector
- Healthcare
- Disclosed range
- $15,001 - $50,000
- 42Well timedAug 4, 2025
Rep. Scott Franklin's NVO buy is up 17% after 30 days
Details
- Politician
- Scott Franklin
- Ticker
- NVO
- Asset
- Novo Nordisk A/S Common Stock (NVO)
- Tx type
- buy
- Tx date
- Aug 4, 2025
- Filing date
- Aug 14, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Amount mid
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 10
- Is whale
- No
- Entry date
- Aug 4, 2025
- Entry close
- 48.81
- Exit date
- Sep 16, 2025
- Exit close
- 57.20
- Forward return
- +17.2%
- Sign adjusted return
- +17.2%
- N trading days
- 30
- 42Well timedAug 4, 2025
Rep. Scott Franklin's NVO buy is up 17% after 30 days
Details
- Politician
- Scott Franklin
- Ticker
- NVO
- Asset
- Novo Nordisk A/S Common Stock (NVO)
- Tx type
- buy
- Tx date
- Aug 4, 2025
- Filing date
- Aug 14, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Amount mid
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 10
- Is whale
- No
- Entry date
- Aug 4, 2025
- Entry close
- 48.81
- Exit date
- Sep 16, 2025
- Exit close
- 57.20
- Forward return
- +17.2%
- Sign adjusted return
- +17.2%
- N trading days
- 30
- 42Well timedAug 4, 2025
Rep. Scott Franklin's NVO buy is up 17% after 30 days
Details
- Politician
- Scott Franklin
- Ticker
- NVO
- Asset
- Novo Nordisk A/S Common Stock (NVO)
- Tx type
- buy
- Tx date
- Aug 4, 2025
- Filing date
- Aug 14, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Amount mid
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 10
- Is whale
- No
- Entry date
- Aug 4, 2025
- Entry close
- 48.81
- Exit date
- Sep 16, 2025
- Exit close
- 57.20
- Forward return
- +17.2%
- Sign adjusted return
- +17.2%
- N trading days
- 30
- 42Well timedAug 4, 2025
Rep. Scott Franklin's NVO buy is up 17% after 30 days
Details
- Politician
- Scott Franklin
- Ticker
- NVO
- Asset
- Novo Nordisk A/S Common Stock (NVO)
- Tx type
- buy
- Tx date
- Aug 4, 2025
- Filing date
- Aug 14, 2025
- Amount low
- $15,001
- Amount high
- $50,000
- Amount mid
- $32,501
- Disclosed range
- $15,001 - $50,000
- Reporting lag days
- 10
- Is whale
- No
- Entry date
- Aug 4, 2025
- Entry close
- 48.81
- Exit date
- Sep 16, 2025
- Exit close
- 57.20
- Forward return
- +17.2%
- Sign adjusted return
- +17.2%
- N trading days
- 30
- 47Well timedJul 10, 2025
Rep. Lisa C. McClain's NVO partial sale avoided a 22% drop over 30 days
Details
- Politician
- Lisa C. McClain
- Ticker
- NVO
- Asset
- Novo Nordisk A/S Common Stock (NVO)
- Tx type
- partial_sale
- Tx date
- Jul 10, 2025
- Filing date
- Aug 13, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Amount mid
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 34
- Is whale
- No
- Entry date
- Jul 10, 2025
- Entry close
- 71.01
- Exit date
- Aug 21, 2025
- Exit close
- 55.45
- Forward return
- -21.9%
- Sign adjusted return
- +21.9%
- N trading days
- 30